Skip to main content
Top
Published in: Drugs 12/2006

01-08-2006 | Adis Drug Profile

Intravenous Ibandronate in the Treatment of Osteoporosis

A Viewpoint by Silvano Adami

Author: Silvano Adami

Published in: Drugs | Issue 12/2006

Login to get access

Excerpt

Bisphosphonates are considered the first-line option for the treatment of postmenopausal osteoporosis. However, the available oral formulations cannot be taken by patients with a number of conditions, such as those with oesophageal abnormalities, cognitive difficulties or inability to follow dose administration instructions (e.g. bedridden) or those taking multiple oral medications. …
Metadata
Title
Intravenous Ibandronate in the Treatment of Osteoporosis
A Viewpoint by Silvano Adami
Author
Silvano Adami
Publication date
01-08-2006
Publisher
Springer International Publishing
Published in
Drugs / Issue 12/2006
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200666120-00008

Other articles of this Issue 12/2006

Drugs 12/2006 Go to the issue

Adis Drug Profile

Intravenous Ibandronate

Adis Drug Evaluation

Entecavir